Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Roster filled: 32 Kansas startups march into Round 2 of tourney-style pitch competition
WICHITA — Nearly three dozen Sunflower State startups are vying for $20,000 in prize money — and courting the attention of investors — as they advance to the second round of an innovative, state-backed pitch competition set amid the excitement of the NCAA Men’s Basketball Tournament. NXTUS on Tuesday announced the initial 32 companies advancing…
Randy Wasinger wanted the 1952 Topps of NFTs; so the lifelong baseball card collector started coding (and Mark Cuban came calling)
Editor’s note: The following includes excerpts from “The Corporate Couch” podcast as part of a collaboration between host Jeff Pelaccio and Startland News to highlight Web3 companies and founders in the space. The 15-year-old boy within Randy Wasinger — so obsessed with baseball cards that he opened a card shop in downtown Russell, Kansas, to sell…
Kansas legislation banning DeepSeek passes to state Senate after swell of support in House
Editor’s note: This article was written for a class at the University of Kansas’ William Allen White School of Journalism and Mass Communications and distributed through the Kansas Press Association. TOPEKA — A bill seeking to ban DeepSeek, a Chinese artificial intelligence chatbot, from state devices has advanced in the Kansas Legislature. HB 2313 passed…
Transportant picked a lane; now the Lenexa bus tech startup wants to conquer even more of the road
From the driver’s seat, Martin Staples is steering Lenexa-based Transportant toward rapid growth with its real-time, tech-driven approach, he said, bringing greater safety, communication, and efficiency to school buses and expanding the startup’s reach beyond its Midwest home region. Fueling Transportant’s plans to leave coast-to-coast tracks — and beyond — will be key, said Staples, who…